title: Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome.
authors.affiliation: University of Tokyo, Tokyo, Japan iwases@ims.u-tokyo.ac.jp.
authors.forename: Satoru
authors.initials: S
authors.lastname: Iwase
authors.affiliation: University of Tokyo, Tokyo, Japan.
authors.forename: Hiroto
authors.initials: H
authors.lastname: Ishiki
authors.affiliation: University of Tokyo, Tokyo, Japan.
authors.forename: Aya
authors.initials: A
authors.lastname: Watanabe
authors.affiliation: University of Tokyo, Tokyo, Japan.
authors.forename: Naoki
authors.initials: N
authors.lastname: Shimada
authors.affiliation: University of Tokyo, Tokyo, Japan.
authors.forename: Tsukuru
authors.initials: T
authors.lastname: Chiba
authors.affiliation: University of Tokyo, Tokyo, Japan.
authors.forename: Junya
authors.initials: J
authors.lastname: Kinkawa
authors.affiliation: University of Tokyo, Tokyo, Japan.
authors.forename: Arinobu
authors.initials: A
authors.lastname: Tojo
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000975:Antioxidants / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives*; D060831:Hand-Foot Syndrome / Q000517:prevention & control*; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage*; D008297:Male; D011322:Primary Prevention / Q000379:methods*; D011788:Quality of Life; D014508:Urea / Q000008:administration & dosage*
chemical_list: D000964:Antimetabolites, Antineoplastic; D000975:Antioxidants; D007641:Keratolytic Agents; D003841:Deoxycytidine; D014508:Urea; D005472:Fluorouracil